After a strong start to the year—as evidenced by the nearly 30% year-over-year increase in the top 10 brands’ first-quarter TV drug ad outlay—spending on pharmaceutical commercials has slowed ...

After spending much of the year sloping steadily downward from a January peak, TV drug ad spending picked up in a major way last month. The combined outlay for the top 10 brands in October weighed in ...

The shape of television media is changing, as consumers shift from linear TV to connected TV and the opportunity of TV advertising becomes more addressable. This transition has prompted a debate about ...

Despite continued uncertainty and mounting regulatory challenges, pharma TV ad spend topped $7 billion through the first 11 months of 2025. Recently released data by iSpot.tv found that the ...

Future linear core TV advertising revenues will continue to decline by 6% to 8% for the next two years, according to MoffettNathanson Research. For 2025, total linear core TV ad revenues are expected ...

In most years, a graph of annual local TV ad spending is about as predictable as an electrocardiogram of a reasonably healthy patient in a doctor’s office. Revenue spikes upwards on even-numbered ...